AVADEL PHARMACEUTICALS PLC Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Avadel Pharmaceuticals Plc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Avadel Pharmaceuticals Plc Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 96.2M shares, a 7.71% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 96.2M +6.88M +7.71% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 96.1M +31.6M +49% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 89.8M +26.9M +42.9% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 89.4M +28.5M +46.8% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 89.3M +30.3M +51.3% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 64.5M +5.45M +9.23% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 62.9M +4.26M +7.26% Dec 31, 2022 10-K 2024-02-29
Q3 2022 60.9M +2.27M +3.87% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 59M +550K +0.94% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 59M +544K +0.93% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 58.6M +224K +0.38% Dec 31, 2021 10-K 2023-03-29
Q3 2021 58.6M +373K +0.64% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 58.5M +359K +0.62% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 58.5M +21M +56.2% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 58.4M +20.9M +55.6% Dec 31, 2020 10-K 2022-03-16
Q3 2020 58.2M +20.8M +55.5% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 58.1M +20.8M +55.6% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 37.5M +95K +0.25% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 37.5M +207K +0.56% Dec 31, 2019 10-K 2021-03-09
Q3 2019 37.5M +438K +1.18% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 37.4M +616K +1.68% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 37.4M -287K -0.76% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 37.3M 0 0% Dec 31, 2018 10-K 2020-03-16
Q3 2018 37M -4.42M -10.7% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 36.7M -4.7M -11.3% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 37.6M -3.74M -9.03% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 37.3M -4.06M -9.81% Dec 31, 2017 10-Q 2019-08-09
Q3 2017 41.4M +194K +0.47% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 41.4M +194K +0.47% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 41.4M +139K +0.34% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 41.4M +130K +0.32% Dec 31, 2016 10-K 2018-03-16
Q3 2016 41.2M Sep 30, 2016 10-Q 2016-11-14
Q2 2016 41.2M +742K +1.83% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 41.2M +988K +2.45% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 41.2M +1.05M +2.61% Dec 31, 2015 10-K 2017-03-28
Q2 2015 40.5M +1.92M +4.97% Jun 30, 2015 6-K 2015-12-31
Q1 2015 40.3M +1.99M +5.19% Mar 31, 2015 6-K 2015-07-10
Q4 2014 40.2M +14.6M +56.9% Dec 31, 2014 10-K 2016-03-15
Q3 2014 38.9M +13.5M +52.9% Sep 30, 2014 6-K 2014-11-17
Q2 2014 38.6M +13.1M +51.5% Jun 30, 2014 6-K 2014-08-08
Q1 2014 38.3M Mar 31, 2014 6-K 2014-07-08
Q4 2013 25.6M +197K +0.78% Dec 31, 2013 20-F/A 2015-10-01
Q3 2013 25.5M Sep 30, 2013 6-K 2014-01-15
Q2 2013 25.5M +308K +1.23% Jun 30, 2013 6-K 2013-12-06
Q4 2012 25.4M +453K +1.82% Dec 31, 2012 20-F/A 2014-04-30
Q2 2012 25.2M Jun 30, 2012 6-K 2012-12-14
Q1 2012 25.2M Mar 31, 2012 6-K 2012-09-13
Q4 2011 25M +317K +1.29% Dec 31, 2011 20-F 2013-04-30
Q4 2010 24.6M Dec 31, 2010 20-F 2012-04-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.